Q J Med 2002; 95: 475-483
© 2002 Association of Physicians
Masterclasses in medicine |
Acute hyponatraemia and ecstasy: insights from a quantitative and integrative analysis
1 From the Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Canada, and 2 Nephrology Unit and Department of Internal Medicine, Stellenbosch University, Cape Town, South Africa
Summary
A 20-year-old woman attended a rave party where she took the drug 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). She had used this drug previously without serious adverse effects. On this occasion, while both she and her friends drank a large quantity of water, only she became seriously ill. The initial manifestation was an altered sensorium; several hours later she had a grand mal seizure. In the Emergency Department, the most striking features were the severe degree of hyponatraemia (112 mmol/l) and cerebral oedema. To explain the basis for this life-threatening clinical presentation, an imaginary consultation was sought with Professor McCance. Using both a deductive and a quantitative analysis that involved several medical subspecialties, he illustrated that a simple story of water ingestion and vasopressin release was not sufficient to explain her hyponatraemia. It was only after events in her gastrointestinal tract were analysed that a plausible hypothesis could be constructed.
Notes
Address correspondence to Professor M.L. Halperin, Professor Medicine, University of Toronto, St Michael's Hospital Annex, Lab #1, Research Wing, 38 Shuter Street, Toronto, Ontario M5B 1A6, Canada. e-mail: mitchell.halperin{at}utoronto.ca
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. van der Hoek, E. J. Hoorn, G. M.T. de Jong, E. N.W. Janssens, and W. W. de Herder Severe Hyponatremia with High Urine Sodium and Osmolality Clin. Chem., November 1, 2009; 55(11): 1905 - 1908. [Full Text] [PDF] |
||||
![]() |
G. A. Campbell and M. H. Rosner The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1852 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.F. Peate, J. C. Ayus, A. Arieff, M. L. Moritz, M. L. Halperin, K. S. Kamel, R. Sterns, C. S.D. Almond, A. Y. Shin, and D. S. Greenes Hyponatremia in Marathon Runners N. Engl. J. Med., July 28, 2005; 353(4): 427 - 428. [Full Text] [PDF] |
||||


